172 related articles for article (PubMed ID: 23806059)
1. A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmacies.
Cocohoba J; Comfort M; Kianfar H; Johnson MO
J Manag Care Pharm; 2013; 19(6):454-60. PubMed ID: 23806059
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
[TBL] [Abstract][Full Text] [Related]
4. Pharmacists' strategies for promoting medication adherence among patients with HIV.
Kibicho J; Owczarzak J
J Am Pharm Assoc (2003); 2011; 51(6):746-55. PubMed ID: 22068197
[TBL] [Abstract][Full Text] [Related]
5. The role of pharmacy personnel in promoting adherence to antiretroviral therapy in the Eastern Cape: communication barriers and breakthroughs.
Rattine-Flaherty E; Burton S
Afr J AIDS Res; 2021 Jul; 20(2):165-171. PubMed ID: 34264163
[No Abstract] [Full Text] [Related]
6. Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.
Krummenacher I; Spencer B; Du Pasquier S; Bugnon O; Cavassini M; Schneider MP
Int J Clin Pharm; 2014 Aug; 36(4):716-24. PubMed ID: 24913358
[TBL] [Abstract][Full Text] [Related]
7. Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.
Barfod TS; Hecht FM; Rubow C; Gerstoft J
BMC Health Serv Res; 2006 Dec; 6():154. PubMed ID: 17144910
[TBL] [Abstract][Full Text] [Related]
8. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.
Dilworth TJ; Klein PW; Mercier RC; Borrego ME; Jakeman B; Pinkerton SD
J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024
[TBL] [Abstract][Full Text] [Related]
10. Where we are now and how we can improve: a qualitative study of practitioners' perspectives on providing ART adherence support in Romania.
Dima AL; Linn AJ; Schweitzer AM
AIDS Care; 2016; 28(5):653-9. PubMed ID: 26678855
[TBL] [Abstract][Full Text] [Related]
11. Potential roles of pharmacists in HIV/AIDS care delivery in Nepal: A qualitative study.
Shahi A; Shrestha S; K C B; Acharya K; Pradhan SK
PLoS One; 2023; 18(1):e0280160. PubMed ID: 36608028
[TBL] [Abstract][Full Text] [Related]
12. Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications.
Smith SR; Golin CE; Reif S
Am J Health Syst Pharm; 2004 Jun; 61(11):1120-9. PubMed ID: 15237564
[TBL] [Abstract][Full Text] [Related]
13. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
[TBL] [Abstract][Full Text] [Related]
14. Improved antiretroviral refill adherence in HIV-focused community pharmacies.
Cocohoba JM; Murphy P; Pietrandoni G; Guglielmo BJ
J Am Pharm Assoc (2003); 2012; 52(5):e67-73. PubMed ID: 23023860
[TBL] [Abstract][Full Text] [Related]
15. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London.
Hesso I; Kayyali R; Nabhani-Gebara S
BMC Health Serv Res; 2019 Jan; 19(1):5. PubMed ID: 30611264
[TBL] [Abstract][Full Text] [Related]
16. Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.
Kibicho J; Pinkerton SD; Owczarzak J; Mkandawire-Valhmu L; Kako PM
J Am Pharm Assoc (2003); 2015; 55(1):19-30. PubMed ID: 25575148
[TBL] [Abstract][Full Text] [Related]
17. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM; Sherman EM; Shafiq S; Hardigan P
J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
[TBL] [Abstract][Full Text] [Related]
19. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.
Marquis J; Schneider MP; Spencer B; Bugnon O; Du Pasquier S
Int J Clin Pharm; 2014 Oct; 36(5):1014-22. PubMed ID: 25139136
[TBL] [Abstract][Full Text] [Related]
20. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
